Vistin Pharma ASA (OSL:VISTN)
20.30
-0.30 (-1.46%)
At close: Jul 15, 2026
Vistin Pharma ASA Balance Sheet
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Short-Term Investments | 6.33 | 16.42 | 12.8 | 26.2 | 1.44 | 35.75 |
Cash Growth | -50.04% | 28.31% | -51.17% | 1726.06% | -95.99% | -53.60% |
Accounts Receivable | 100.16 | 89.71 | 44.28 | 47.02 | 66.16 | 40.25 |
Other Receivables | 28.12 | 15.26 | 9.45 | 15.38 | 8.15 | 18.93 |
Total Trade Receivables | 128.28 | 104.97 | 53.73 | 62.4 | 74.3 | 59.18 |
Inventory | 82.93 | 82.13 | 76.67 | 80.17 | 83.45 | 42.91 |
Total Current Assets | 217.54 | 203.52 | 143.19 | 168.77 | 159.18 | 137.83 |
Net Property, Plant & Equipment | 223.87 | 223.75 | 229.6 | 219.98 | 219.43 | 167.46 |
Long-Term Investments | 12.15 | 12.15 | 12.15 | - | - | - |
Other Long-Term Assets | - | - | - | 14.64 | 28.6 | 27.86 |
Total Assets | 453.56 | 439.43 | 384.95 | 403.4 | 407.21 | 333.15 |
Accounts Payable | 25.41 | 30.24 | 13.05 | 18.92 | 25.91 | 20.81 |
Accrued Expenses | - | 7.73 | - | - | - | - |
Short-Term Debt | - | - | - | - | 45.14 | - |
Other Current Liabilities | 48.11 | 48.75 | 50.91 | 50.56 | 46.53 | 20.23 |
Total Current Liabilities | 73.52 | 86.72 | 63.97 | 69.47 | 117.57 | 41.04 |
Other Long-Term Liabilities | 29.74 | 23.9 | 11.45 | 11.15 | 16.16 | 16.34 |
Total Long-Term Liabilities | 29.74 | 23.9 | 11.45 | 11.15 | 16.16 | 16.34 |
Total Liabilities | 103.25 | 110.62 | 75.41 | 80.62 | 133.73 | 57.38 |
Common Stock | 44.35 | 44.35 | 44.35 | 44.35 | 44.35 | 44.35 |
Additional Paid-in Capital | 73.87 | 73.87 | 129.3 | 206.89 | 206.89 | 206.89 |
Retained Earnings | 232.09 | 210.6 | 135.89 | 71.54 | 22.26 | 24.54 |
Shareholders' Equity | 350.31 | 328.81 | 309.53 | 322.77 | 273.49 | 275.77 |
Total Liabilities & Equity | 453.56 | 439.43 | 384.95 | 403.4 | 407.21 | 333.15 |
Total Debt | - | 0 | 0 | 0 | 45.14 | 0 |
Net Cash (Debt) | 6.33 | 16.42 | 12.8 | 26.2 | -43.71 | 35.75 |
Net Cash Growth | -61.45% | 28.31% | -51.17% | - | - | -53.60% |
Net Cash Per Share | 0.14 | 0.37 | 0.29 | 0.59 | -0.99 | 0.81 |
Book Value | 350.31 | 328.81 | 309.53 | 322.77 | 273.49 | 275.77 |
Book Value Per Share | 7.90 | 7.41 | 6.98 | 7.28 | 6.17 | 6.22 |
Tangible Book Value | 350.31 | 328.81 | 309.53 | 322.77 | 273.49 | 275.77 |
Tangible Book Value Per Share | 7.90 | 7.41 | 6.98 | 7.28 | 6.17 | 6.22 |